Results

Total Results: 1,653 records

Showing results for "described".

121. BLUEPRINT FOR A FUTURE DISTRIBUTED RESEARCH NETWORK (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-blueprint_research.pdf
     June 01, 2010 - proof-of-principle implementation of a network prototype demonstrating some of the design features described … rationale, goals, potential uses, and challenges associated with a distributed research network have been described … Key Features of the Network The key features of the network are described below. … Query Distribution A “pull” mechanism (also described as publish-and-subscribe or polling) in which … Summary/Conclusions The blueprint described above presents a systematic approach to building the infrastructure

122. S166 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/s166.pdf
     October 01, 2007 - (eg, active treatment A vs. placebo compared with active treatment B vs. placebo) using the methods described … standard techniques of random effects meta-analysis of con- tinuous variables using inverse variance as described … We combined the direct estimate with the indirect estimate from the current study using the method described … We recalculated the direct com- parison frequentist meta-analyses described above using these Bayesian … comparisons can be duplicated using Bayesian methods by a process known as the Mixed Treatment Com- parison, described

123. Rapid Evidence Product_Assisted Home Dialysis in the United States: New Interest in an Old Idea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/home-dialysis-ESKD-rapid-research.pdf
     April 01, 2025 - They described different levels of assistance, with some patients requiring minimal help and others … Additionally, an older Canadian study described their experience with a respite care program for home … As described above, the Satellite Healthcare pilot assisted PD program focused on temporary assistance … Canada In the multicenter study in British Columbia described above, the investigators compared outcomes … Patients were allowed 2 weeks/year of relief dialysis. 3 months training (not described) Respite

124. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
     January 01, 2010 - The definitions and ratings criteria are very well described. … How is this question different from what was described for Questions 3a/b/c? … are described as “SS ↓”? … We have reviewed these guidelines to ensure they have been described accurately. … These have been described in the preceding comments.

125. Disposition of Comments_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforce (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-disposition-comments.pdf
     February 28, 2025 - In addition, mental health-related issues are described for EMS clinicians but again, not similarly … described for telecommunicators. … not deterred from future research on EMS workers. 22 Peer Reviewer #3 Methods Based on the methods described … The limitations are clearly described.

126. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - The mechanisms underlying the use of phenotypic tests for platelet reactivity are described in detail … However, the study results have not been published and were not included in the analysis described in … We recognize that a cutoff date for including studies in the analysis described in the draft report … As described above, there are significant fundamental differences between the test methods evaluated … Both of these points are described in more detail above.

127. Disposition of Comments for CER 196 The Role of Immunotherapy in the Treatment of Asthma (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-196-disposition-comments-immunotherapy-asthma.pdf
     March 23, 2018 - The PICOTS framework and the attribution of specific measures to each area are well described. … The statistical methods are well described and appropriate. … The characteristics of the studies are clearly described. The tables contain good detail. … Limitations are appropriately described, as is the Future Research section. … Characteristics of the studies are clearly described in the text and table 2.

128. DEcIDE 34 - Developing a Registry of Patient Registries: Options for the Agency for Healthcare Research and Quality (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/registry-of-patient-registries-development_research_0.pdf
     February 01, 2012 - , and only 7,000 are described as prospective observational studies. … As described further below, these actions have successfully led to large increases in the listing of … Clinicaltrials.gov provides an excellent model for the study-listing component described in Table 1. … As described earlier, there would be incremental gain in each additional function supported by such … These requirements are described in detail in Table 1.

129. Disposition of Comments_Comparative Effectiveness Review No. 274: Diagnosis and Treatment of Tethered Spinal Cord (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-274-tethered-spinal-cord-disposition-comments.pdf
     October 25, 2024 - There are still limited studies on the subgroups of tethered cord patients that a reviewer described … We checked and we could not find this text Public Reviewer 1 Methods The methods are clearly described

130. Slide 1
     effectivehealthcare.ahrq.gov/sites/default/files/sensitivity-analysis-chapter-11.pptx
     January 01, 2013 - software-based Statistical software-based approaches can be helpful where the association is not well described … The presentation proposed and described planned sensitivity analyses, described important subpopulations … in which measures of effect will be assessed for homogeneity, described modeling assumptions and how

131. Disposition of Comments Report for The Patient-Centered Medical Home (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/patient-centered-medical-home_disposition-comments.pdf
     July 03, 2012 - Key questions are well-defined and described. Thank you for the comment. … Peer Reviewer 3 Results Overall, the level of detail is appropriate, studies are clearly described, … Study characteristics are clearly described. … SOE was defined as described in the Methods (see Strength of Body of Evidence). … Instead, studies focus on the process of care, as described by the reviewer.

132. Methods-Guidance-Reporting-Bias Methods (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-reporting-bias_methods.pdf
     November 01, 2013 - As a third example, given the fact that only 60 percent of randomized controlled trials (RCTs) described … Background Definitions and History The Institute of Medicine has recently described reporting bias … For abstracts that were clearly described, primary endpoints were identical in 90 percent of cases; … Alternatively, EPCs could also construct a matrix as described by Kirkham et al.23 and illustrated by … Reporting the Search Strategy and Results General Guidelines As described more fully in the chapter

133. Medical-Evidence-Communication Research-Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/medical-evidence-communication_research-protocol.pdf
     July 31, 2012 - nurses, midlevel providers, and/or pharmacists Interventions Specific clinical interventions are described … Comparators Alternate presentations of the specified interventions Outcomes Specific outcomes are described … As described above, evidence dissemination has several broad goals. … The steps that we will take to accomplish the literature review are described below. … review each full-text article for inclusion or exclusion on the basis of the eligibility criteria described

134. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/depression-postpartum-screening_research-protocol.pdf
     May 01, 2013 - instruments, health-related quality of life, and health-system resource utilization (measured as described … Data necessary for assessing quality and applicability, as described in the Methods Guides, will also … The strength of evidence will be assessed by using the approach described in the Methods Guides.30,31,38 … Assessing Applicability We will assess applicability across our KQs using the method described in … The strength of evidence will be assessed by using the approach described in the Methods Guides.30,31,38

135. Comparative Effectiveness Review Disposition of Comments Report (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/bundled-payments-quality-effects_disposition-comments.pdf
     August 24, 2012 - should note in the Executive Summary, that many of the interventions themselves are incompletely described … added the following sentence to the abstract: “The interventions studied were often incompletely described … But these programs are not described. … The effect described sounds like regression to the mean rather than an intervention effect. … Items described above: Items 1 through 3 above suggest obvious additional areas of research.

136. Disposition of Comments for Technical Brief 28 MAT Models (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/opioid-use-disorder_disposition-comments.pdf
     December 06, 2016 - The need to evaluate prescribing of buprenorphine by non- physician providers is described as a future … Pharmacy-based models are described in the New and Innovative Strategies section and research in this … In addition, as described in the Brief, pharmacists are partnering with physicians to provide MAT.9 … Misstated information-it turns out that the Hub and Spoke model does NOT function as described. … The mortality associated with opioid use disorder is described earlier in this section.

137. The Refinement of Topics for Systematic Reviews: Lessons and Recommendations From the Effective Health Care Program (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-refinement_methods.pdf
     January 01, 2013 - Our work group followed previously described basic principles for developing methods guidance in the … EPC program.9 As a first step, work group members each described their own EPC’s approach to topic … The AHRQ Project Officer then described successful and unsuccessful procedures used by other EPCs not … described public accountability as an ethical requirement for topic identification and selection in … These changes have been incorporated into an updated document (Appendix A) and are described in the

138. Evidence-based Practice Center Systematic Review Protocol (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/tethered-spinal-cord-protocol.pdf
     July 19, 2023 - On the other hand, spinal column shortening to decrease spinal cord tension has been described and utilized … Discussions with the TEP also informed pre-planned subgroup analyses described in the data synthesis … Following the described input, the final key questions are as follows: Key Question 1: What is the … Data necessary for assessing quality and applicability as described in the EPC Methods Guide will also … The strength of the evidence may be downgraded based on the limitations described above.

139. Psychosocial and Pharmacologic Interventions for Disruptive Behavior in Children and Adolescents (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol.pdf
     January 31, 2023 - Criteria for Inclusion/Exclusion of Studies in the Review: We will use the inclusion/exclusion criteria described … Effectiveness Reviews.18 Studies will be rated as being “low,” “moderate,” or “high” risk of bias as described … initially assessed by one researcher for each clinical outcome (see PICOTS) by using the approach described … The strength of the evidence may be downgraded based on the limitations described above. … existence of plausible unmeasured confounders), if there are no downgrades on the primary domains, as described

140. Mental-Illness-Heart Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
     April 01, 2013 - Study Selection Using the prespecified inclusion and exclusion criteria described in Table 2 of the … For citations retrieved by searching the gray literature, the above-described procedures were modified … Data necessary for assessing quality and applicability, as described in the Methods Guide,35 were also … Individual Studies We evaluated the quality of individual studies using the key criteria for RCTs described … Applicability We assessed applicability across our KQs using the method described in the Methods Guide